Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrine Fabricius

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neuroscience Letters|July 20, 2010
Increased dopaminergic activity in socially isolated rats: an electrophysiological studyKatrine Fabricius, Lone Helboe, Anders Fink-Jensen, et al.
Magnetic Resonance Imaging|December 15, 2012
Application of stereological methods to estimate post-mortem brain surface area using 3T MRICarolyn Furlong, Marta García-Fiñana, Michael Puddephat, et al.
Plos One|August 13, 2015
A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating AgentsLouise S Dalbøge, Philip J Pedersen, Gitte Hansen, et al.
Brain Research|January 10, 2016
The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathyHenrik H Hansen, Pernille Barkholt, Katrine Fabricius, et al.
Brain Research|May 29, 2016
Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's diseaseHenrik H Hansen, Katrine Fabricius, Pernille Barkholt, et al.
Journal of Neurochemistry|October 23, 2012
Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated ratsSanne S Kaalund, Jesper Riise, Brian V Broberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 6, 2018
Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in miceEsben M Bech, Kristoffer Voldum-Clausen, Søren L Pedersen, et al.
Plos One|July 16, 2016
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's DiseaseHenrik H Hansen, Katrine Fabricius, Pernille Barkholt, et al.
Journal of Alzheimer'S Disease : JAD|April 15, 2015
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's DiseaseHenrik H Hansen, Katrine Fabricius, Pernille Barkholt, et al.
Scientific Reports|November 1, 2019
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese miceMette Simone Aae Madsen, Jacob Bak Holm, Albert Pallejà, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neuroscience Letters|July 20, 2010
Increased dopaminergic activity in socially isolated rats: an electrophysiological studyKatrine Fabricius, Lone Helboe, Anders Fink-Jensen, et al.
Magnetic Resonance Imaging|December 15, 2012
Application of stereological methods to estimate post-mortem brain surface area using 3T MRICarolyn Furlong, Marta García-Fiñana, Michael Puddephat, et al.
Plos One|August 13, 2015
A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating AgentsLouise S Dalbøge, Philip J Pedersen, Gitte Hansen, et al.
Brain Research|January 10, 2016
The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathyHenrik H Hansen, Pernille Barkholt, Katrine Fabricius, et al.
Brain Research|May 29, 2016
Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's diseaseHenrik H Hansen, Katrine Fabricius, Pernille Barkholt, et al.
Journal of Neurochemistry|October 23, 2012
Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated ratsSanne S Kaalund, Jesper Riise, Brian V Broberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 6, 2018
Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in miceEsben M Bech, Kristoffer Voldum-Clausen, Søren L Pedersen, et al.
Plos One|July 16, 2016
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's DiseaseHenrik H Hansen, Katrine Fabricius, Pernille Barkholt, et al.
Journal of Alzheimer'S Disease : JAD|April 15, 2015
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's DiseaseHenrik H Hansen, Katrine Fabricius, Pernille Barkholt, et al.
Scientific Reports|November 1, 2019
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese miceMette Simone Aae Madsen, Jacob Bak Holm, Albert Pallejà, et al.
Pageof 3